Cargando…
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods
Human urate anion transporter 1 (hURAT1) is responsible for the reabsorption of uric acid in the proximal renal tubules and is a promising therapeutic target for treating hyperuricemia. To mitigate the side effects of URAT1-targeted clinical agents such as benzbromarone, there is significant interes...
Autores principales: | Chen, Ying, You, Ruya, Wang, Ke, Wang, Yousheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572588/ https://www.ncbi.nlm.nih.gov/pubmed/34754317 http://dx.doi.org/10.1155/2021/5738900 |
Ejemplares similares
-
Recent Advances in Synthetic Drugs and Natural Actives Interacting with OAT3
por: Chen, Ying, et al.
Publicado: (2023) -
Discovery of Novel Biphenyl Carboxylic Acid Derivatives as Potent URAT1 Inhibitors
por: Hou, Xianxin, et al.
Publicado: (2023) -
Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates
por: Coricello, Adriana, et al.
Publicado: (2020) -
Virtual screening and activity evaluation of human uric acid transporter 1 (hURAT1) inhibitors
por: Yang, Yacong, et al.
Publicado: (2023) -
Mechanism of high affinity inhibition of the human urate transporter URAT1
por: Tan, Philip K., et al.
Publicado: (2016)